Skip to main content
logo
Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1296
-0.0022 (-1.67%)
Sep 4, 2026, 5:29 PM CET

Immunovia AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.210.690.931.581.150.84
Revenue Growth
31.77%-26.42%-40.89%37.55%35.66%133.15%
Gross Profit
0.690.550.93-5.11-3.0715.81
Operating Income
-82.81-80.45-110.17-296.69-191.21-166.74
Net Income
-88.34-145.92-76.54-309.44-168.09-155.97
Earnings Per Share
-0.16-0.42-0.93-7.95-7.43-6.89
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
34.977.4625.3276.79106.04287.41
Total Debt
3.270.860.6810.2737.5733.26
Net Cash (Debt)
31.6376.624.6466.5268.47254.14
Net Cash Growth
9.81%210.91%-62.96%-2.84%-73.06%-41.62%
Net Cash Per Share
0.060.220.301.713.0311.23

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-77.35-78.4-96.75-147.06-175.58-152.65
Capital Expenditures
-----1.26-3.1
Free Cash Flow
-77.35-78.4-96.75-147.06-176.84-155.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.98%80.15%100.00%--267.77%1873.58%
Operating Margin
-6838.40%-11744.82%-11833.94%-18837.27%-16699.48%-19756.04%
Pretax Margin
-7294.38%-21301.46%-8221.37%-19646.92%-14680.52%-18479.38%
Profit Margin
-7294.39%-21301.46%-8221.38%-19646.92%-14680.52%-18479.38%
FCF Margin
-6387.37%-11445.26%-10392.37%-9336.95%-15444.37%-18453.67%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
71.99222.9199.5350.95519.842011.10